Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: NETEC
Subject: Emergency Management
Item Type: Webinar
Date Last Updated: 2021-11-12
Description: Join us Friday, November 12th, at 12pm CST for the next NETEC COVID-19 Webinar Series presentation, Influenza in the Age of COVID: 2021 Seasonal Update. Join our presenters as they discuss important topics surrounding the upcoming 2021 influenza… -
Creator: Li, L., L. B. Robinson, R. Patel, A. B. Landman, X. Fu, E. S. Shenoy, D. M. Hashimoto, A. Banerji, P. G. Wickner, U. Samarakoon, C. M. Mancini, Y. Zhang, and K. G. Blumenthal.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-10-01
Description: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after receiving the vaccine are unknown. -
Creator: University of Nebraska Medical Center / Nebraska Medicine
Subject: Infection Control
Item Type: Webinar
Date Last Updated: 2021-10-28
Description: Region VII Regional Emerging Special Pathogen Treatment Center (RESPTC) Perils and Pearls Zoomcast: Episode 22: Mpox.
Please join Infectious Disease experts, Dr. Agam Rao and Dr. David Brett-Major as they provide up-to-date information on Mpox and… -
-
-
-
Creator: Bar-On, Yinon M., Yair Goldberg, Micha Mandel, Omri Bodenheimer, Laurence Freedman, Nir Kalkstein, Barak Mizrahi, Sharon Alroy-Preis, Nachman Ash, Ron Milo, and Amit Huppert.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-10-07
Description: On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5… -
Creator: the BLAZE-1 Investigators
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-10-07
Description: Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and… -
Creator: Barbaro, Ryan P., Graeme MacLaren, Philip S. Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, Rodrigo Diaz, Eddy Fan, Katarzyna Hryniewicz, Roberto Lorusso, Matthew L. Paden, Christine M. Stead, Justyna Swol, Theodore J. Iwashyna, Arthur S.…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-09-29
Description: Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to examine patient selection, treatments, outcomes, and ECMO centre… -
Creator: Xia, ShengLi, YunTao Zhang, YanXia Wang, Hui Wang, YunKai Yang, George Fu Gao, WenJie Tan, GuiZhen Wu, Miao Xu, ZhiYong Lou, WeiJin Huang, WenBo Xu, BaoYing Huang, Wei Wang, Wei Zhang, Na Li, ZhiQiang Xie, Xiujuan Zhu, Ling Ding, WangYang You, YuXiu…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-09-15
Description: Although SARS-CoV-2 infection often causes milder symptoms in children and adolescents, young people might still play a key part in SARS-CoV-2 transmission. An efficacious vaccine for children and adolescents could therefore assist pandemic control.…